Enveric Biosciences, Inc. (ENVB) News
Follow Enveric Biosciences, Inc. (ENVB) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 8 public stories across 5 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
ENVB - Enveric Biosciences Secures New U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 Series
ENVB - Enveric Biosciences Secures New U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 Series
NEWS | Sep 15, 2026, 12:05 PM UTC
L
Enveric Biosciences Secures New U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 Series
Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced tha
NEWS | Sep 15, 2026, 12:01 PM UTC
L
Enveric Biosciences to present at H.C. Wainwright conference
Enveric Biosciences says it will present at H.C. Wainwright 28th Annual Global Investment Conference.
EQUITY | Sep 01, 2026, 12:38 PM UTC
L
Enveric Biosciences CEO Joseph Tucker to deliver virtual conference presentation
Enveric Biosciences said Joseph Tucker, Ph.D., its CEO, will deliver a virtual presentation at the H.C. Wainwright 28th Annual Global Investment Conference.
EQUITY | Sep 01, 2026, 12:30 PM UTC
L
Enveric Biosciences reports Q2 2026 financial results, corporate update
Enveric Biosciences (ENVB) reports financial results and provides a corporate update for second quarter 2026.
EARNINGS | Aug 14, 2026, 08:12 PM UTC
H
Enveric Biosciences Announces New Preclinical Data That Further Supports The Non-Hallucinogenic Profile Of EB-003; GloSensor Assay Findings
Preclinical testing of EB-003 was conducted using a targeted, highly sensitive GloSensor™ cAMP assay, which has been previously described in peer-reviewed scientific literature (Wang et al., 2022)1. The Promega GloSensor
REGULATION | Aug 05, 2026, 12:08 PM UTC
M
Enveric Biosciences Reports Non-Hallucinogenic Data
Enveric Biosciences reports preclinical data on EB-003
EQUITY | Aug 05, 2026, 12:02 PM UTC
L
Enveric 'welcomes' final FDA guidance for psychedelic drug development
Enveric Biosciences...
EARNINGS | Jul 28, 2026, 12:05 PM UTC